{"product_id":"novara-t","title":"Novara-T™","description":"\u003cp\u003e\u003cstrong\u003ePersonalized Cancer Support System\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNovara-T™\u003c\/strong\u003e is an advanced precision oncology support solution designed for confirmed cancer cases where personalized immune-recognition planning may be required.\u003c\/p\u003e\n\u003cp\u003eCancer cells are not always easily recognized by the immune system. Over time, they may develop ways to hide, change their surface signals, or reduce immune visibility. This can make it harder for the body’s natural defense system to identify abnormal cells effectively.\u003c\/p\u003e\n\u003cp\u003eNovara-T™ is developed around a personalized tumor-intelligence concept. It focuses on using patient-specific tumor-associated biological information to support immune recognition, allowing a more tailored and targeted oncology support strategy.\u003c\/p\u003e\n\u003cp\u003eThis makes Novara-T™ suitable for patients who require a more individualized immune-focused approach as part of doctor-led cancer management.\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eWHAT NOVARA-T™ IS?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNovara-T™ is a \u003cstrong\u003epersonalized tumor antigen intelligence platform.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIt is designed to support the immune system by introducing selected tumor-associated biological information derived from the patient’s own cancer profile.\u003c\/p\u003e\n\u003cp\u003eIn cancer biology, tumor cells may carry unique signatures that differentiate them from normal healthy cells. These signatures may include tumor-related surface patterns, structural components, protein fragments, cellular signals, and other biological markers linked to abnormal cancer-cell behavior.\u003c\/p\u003e\n\u003cp\u003eNovara-T™ is designed to help create a clearer immune reference profile so the body’s defense system can better recognize tumor-associated signals.\u003c\/p\u003e\n\u003cp\u003eIn simple terms:\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNovara-T™ helps the immune system better understand what it needs to recognize.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eHOW \u003cmeta charset=\"utf-8\"\u003eNOVARA-T™ WORKS?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe process begins with a patient-specific cancer-cell and immune assessment.\u003c\/p\u003e\n\u003cp\u003eThrough advanced profiling, the patient’s tumor-associated biological information is reviewed. This helps identify relevant antigenic patterns and immune-related signals that may be useful for personalized planning.\u003c\/p\u003e\n\u003cp\u003eOnce the patient’s cancer profile and immune readiness are assessed, Novara-T™ is prepared as a personalized immune-recognition support product.\u003c\/p\u003e\n\u003cp\u003eThe goal is to provide the immune system with a more specific tumor-associated reference, helping support immune awareness and recognition.\u003c\/p\u003e\n\u003cp\u003eInstead of only asking:\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e“What type of cancer does the patient have?”\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNovara-T™ goes further and asks:\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e“What unique tumor signals does this patient’s immune system need to recognize?”\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eWHAT MAKES \u003cmeta charset=\"utf-8\"\u003eNOVARA-T™ DIFFERENT?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePersonalized to Each Patient\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eNovara-T™ is developed based on the patient’s own tumor-associated biological profile. It is not a standard, one-size-fits-all product.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTumor-Antigen Intelligence\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eIt focuses on tumor-associated recognition signals rather than general immune stimulation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eImmune Recognition Support\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eNovara-T™ is designed to support the immune system’s ability to identify cancer-related biological patterns more clearly.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNon-Live-Cell Concept\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eNovara-T™ is not a live-cell infusion product. It is not NK cell therapy and not CAR-T therapy. It works through a tumor-antigen intelligence concept that supports immune recognition.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDesigned for Precision Oncology\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eNovara-T™ supports a more individualized oncology strategy by combining cancer-cell information with immune-status review.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Doctor-Led Planning\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eNovara-T™ is intended to be used as part of a professional oncology support plan, under the supervision of qualified healthcare personnel.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eKEY BENEFITS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Personalized Immune Recognition\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eHelps provide tumor-associated information that may support immune awareness.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGuides Immune-Focused Oncology Planning\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eUseful when doctors want to explore whether immune-recognition support is suitable for the patient.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUses Patient-Specific Tumor Intelligence\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eDeveloped based on the patient’s own cancer-related biological profile.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComplements Advanced Cancer-Cell Profiling\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eCan be considered alongside blood-based cancer-cell assessment and immune-status profiling.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports a More Targeted Support Strategy\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eHelps move beyond generic immune support toward a more personalized, data-guided approach.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eWHO \u003cmeta charset=\"utf-8\"\u003eNOVARA-T™ IS DESIGNED FOR?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNovara-T™ is designed for \u003cstrong\u003econfirmed cancer patients\u003c\/strong\u003e who may require personalized immune-recognition support as part of a professional oncology plan.\u003c\/p\u003e\n\u003cp\u003eIt may be considered for patients who:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ehave a confirmed cancer diagnosis\u003c\/li\u003e\n\u003cli\u003erequire deeper cancer-cell profiling before planning\u003c\/li\u003e\n\u003cli\u003eare exploring personalized oncology support\u003c\/li\u003e\n\u003cli\u003emay benefit from immune-recognition assessment\u003c\/li\u003e\n\u003cli\u003erequire doctor-led immune-focused planning\u003c\/li\u003e\n\u003cli\u003eare undergoing advanced cancer management review\u003c\/li\u003e\n\u003cli\u003eneed a more individualized strategy beyond general wellness care\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSuitability depends on professional review of:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ecancer type\u003c\/li\u003e\n\u003cli\u003edisease stage\u003c\/li\u003e\n\u003cli\u003etumor burden\u003c\/li\u003e\n\u003cli\u003eimmune status\u003c\/li\u003e\n\u003cli\u003ecurrent treatment status\u003c\/li\u003e\n\u003cli\u003eblood-based cancer-cell findings\u003c\/li\u003e\n\u003cli\u003eimaging results\u003c\/li\u003e\n\u003cli\u003emedical history\u003c\/li\u003e\n\u003cli\u003eorgan function\u003c\/li\u003e\n\u003cli\u003eoverall clinical condition\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eNovara-T™ may not be suitable for every patient, especially where immune function is severely compromised. A professional medical review is required before use.\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eRECOMMENDED PRE-ASSESSMENT\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBefore Novara-T™ can be considered, patients should undergo appropriate professional evaluation to assess:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ecancer-cell profile\u003c\/li\u003e\n\u003cli\u003etumor-associated biological signals\u003c\/li\u003e\n\u003cli\u003eimmune activation or suppression status\u003c\/li\u003e\n\u003cli\u003ecurrent treatment history\u003c\/li\u003e\n\u003cli\u003esuitability for immune-recognition support\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis helps ensure that Novara-T™ is used only when the patient’s condition and immune status are suitable.\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eIMPORTANT NOTICE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNovara-T™ is intended for professional and doctor-supervised use only. It is not chemotherapy, radiation therapy, NK cell therapy, or CAR-T therapy. It is not intended to diagnose, treat, cure, or prevent any disease as a standalone product.\u003c\/p\u003e\n\u003cp\u003eSuitability must be determined by qualified medical professionals based on the patient’s clinical condition, cancer profile, immune status, investigation results, and overall treatment plan.\u003c\/p\u003e","brand":"Cell Tissue","offers":[{"title":"Default Title","offer_id":44191348916260,"sku":"CTNOVT0074","price":39999.0,"currency_code":"MYR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/8665\/8084\/files\/CellTissueUKMNovara-T01_e18a6724-9c0c-416b-b2ac-025aee670920.jpg?v=1779183599","url":"https:\/\/shop.cytolifeasia.com\/products\/novara-t","provider":"CytoLife","version":"1.0","type":"link"}